postural orthostatic tachycardia syndrome
GPTKB entity
Statements (48)
Predicate | Object |
---|---|
gptkbp:instanceOf |
syndrome
|
gptkbp:abbreviation |
gptkb:POTS
|
gptkbp:affects |
autonomic nervous system
|
gptkbp:category |
gptkb:cardiovascular_disease
neurological disorder dysautonomia |
gptkbp:cause |
autonomic nervous system dysfunction
|
gptkbp:complication |
disability
reduced quality of life |
gptkbp:diagnosis_criterion |
absence of orthostatic hypotension
increase in heart rate of at least 30 bpm within 10 minutes of standing |
gptkbp:duration |
chronic
|
gptkbp:firstDescribed |
1993
|
gptkbp:frequency |
rare
|
gptkbp:gender |
more common in females
|
gptkbp:hasDiagnosticMethod |
heart rate monitoring
tilt table test |
https://www.w3.org/2000/01/rdf-schema#label |
postural orthostatic tachycardia syndrome
|
gptkbp:ICD-10_code |
gptkb:G90.9
|
gptkbp:MeSH_ID |
gptkb:D000072633
|
gptkbp:onset |
adolescence or early adulthood
|
gptkbp:prevalence |
estimated 1-3 million people in the United States
|
gptkbp:prognosis |
variable
|
gptkbp:relatedTo |
gptkb:mast_cell_activation_syndrome
gptkb:orthostatic_intolerance Ehlers-Danlos syndrome chronic fatigue syndrome |
gptkbp:riskFactor |
adolescence
female sex recent viral illness |
gptkbp:specialty |
cardiology
neurology |
gptkbp:symptom |
nausea
dizziness fatigue tachycardia palpitations syncope lightheadedness |
gptkbp:treatment |
gptkb:fludrocortisone
gptkb:midodrine beta blockers exercise compression stockings increased fluid intake increased salt intake |
gptkbp:bfsParent |
gptkb:The_Autonomic_Nervous_System
|
gptkbp:bfsLayer |
6
|